Chemkart India Ltd Company Summary

Chemkart India Limited was established on March 6, 2020 as Chemkart India Private Limited, a private limited company with the Deputy Registrar of Companies. Further, Company was converted into a public limited company and the name was changed to Chemkart India Limited and a fresh certificate of incorporation dated October 04, 2024 was issued by the Central Processing Centre. The Company is mainly engaged in the business of Processing and Trading of Nutritional and Health Supplements.

It offer products across seven product categories, i.e. Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin. The Company also engages actively with their suppliers to improve the supply chain processes.

The Company carries out the operations from the registered office in Mumbai, Maharashtra and operate a warehousing facility at Bhiwandi, consisting of blending and grinding equipment to further process the products and store them being traded to ensure easy supply chain mechanism. The in-built processing and blending facility have a capacity of 1.8 M.T. per day equivalent to 540 M.T.

per year from the grindingmachine and 1.5 M.T. per day equivalent to 450 M.T. per year from the blending machine.

The in-built processing and blending facility specialize in processing raw materials such as L-Leucine Instant, L-Isoleucine, L-Valine, L-Histidine, L-Lysine HCL, DL-Methionine, L-Threonine, L-Phenylalanine, l-tryptophane. Company has adopted technologies namely Zoho and Xemi systems across its office and warehouse which helps in increasing productivity and efficiency.The Company launched the IPO by issuing 32,29,200 equity shares of Rs 10 each, by raising Rs 80.08 crores, comprising a fresh issue of 26,00,000 equity shares aggregating to Rs 64.48 crores and the offer for sale of 6,29,200 equity shares aggregating to Rs 15.6 crores in July, 2025.